Biotech Values

[biomaven0]

>>AMGN’s COO thinks ICER’s proposed $8,500/yr price for Aimovig is reasonable, according to yesterday’s 1Q18 CC.

Very interesting. I have a friend who works at ICER and their researchers actually did an interview with me on my migraine experiences and thoughts.

This does indeed seem reasonable pricing - not a huge step-up from Botox. I think ICER previously pegged annual cost of Botox at close to $8k, although I think in practice it's more like $6k.